The company will provide the response and corrective action plan within the 15 working days to address the USFDA observation
The share price of Unichem Laboratories declined more than 3 percent intraday on August 26 after the company received one observation from USFDA
The United States Food and Drug Administration (USFDA) conducted an inspection at the company's Ghaziabad formulation facility between August 19, 2019, to August 23, 2019.
The inspection was a routine GMP surveillance and at the end of the inspection, the facility received one observation which is not a repeat observation and is procedural in nature.
The company will provide the response and corrective action plan within the next 15 working days to address the USFDA observation, it added.
Unichem Laboratories was quoting at Rs 170.15, down Rs 2.50, or 1.45 percent on the BSE.
Get Best Stock Options Tips For More Updates in Stock Market Tips Give a Missed call @9644405057 and Get Free Trial
No comments:
Post a Comment